Скачать или смотреть 𝗖𝗔𝗡𝗖𝗘𝗥 𝗧𝗥𝗘𝗔𝗧𝗠𝗘𝗡𝗧 𝗙𝗥𝗢𝗠 𝗦𝗡𝗔𝗞𝗘 𝗩𝗘𝗡𝗢𝗠? 𝗖𝗘𝗟𝗧𝗜𝗖 𝗕𝗜𝗢𝗧𝗘𝗖𝗛'𝗦 𝗖𝗕𝟮𝟰 𝗧𝗔𝗥𝗚𝗘𝗧𝗦 𝗧𝗨𝗠𝗢𝗥𝗦 𝗪𝗜𝗧𝗛 𝗗𝗘𝗔𝗗𝗟𝗬 𝗣𝗥𝗘𝗖𝗜𝗦𝗜𝗢𝗡🐍💉

In this gripping drug discovery spotlight, we explore how Irish biotech company Celtic Biotech is advancing CB24, a tumor-targeting biologic derived from rattlesnake venom. This anti-cancer therapy uses venom's natural cell-targeting abilities to destroy tumors—without damaging healthy tissue.

Learn how CB24 selectively disrupts cancer cell membranes, modulates immune responses, and shows promise in early clinical trials for prostate, pancreatic, and metastatic cancers.

🚀 Highlights:

Evolutionary science behind venom-derived drugs

CB24’s unique tumor selectivity

Clinical trial progress and regulatory milestones

Market opportunities and platform expansion

💡 Could snake venom be the future of oncology? Watch to find out.

👉 Subscribe for more nature-inspired biotech stories, startup spotlights, and breakthrough therapies.

🔗 Learn more: [Insert Celtic Biotech Website or ClinicalTrials.gov link]

#CancerTreatment #SnakeVenomDrug #CelticBiotech #CB24 #BiotechInnovation #NatureInspiredMedicine #TumorTargeting #OncologyBreakthrough